Prostate cancer education session planned
The Prostate Cancer Foundation of New Zealand wants men living with advanced prostate cancer, and their families, to learn more about the disease and take an active role in defining their health outcomes.
‘‘Current treatment options are limited for men who have prostate cancer that has become resistant to hormone treatment,’’ Professor Chris Atkinson, oncologist and medical director of the Cancer Society says.
‘‘By providing men, and their families with detailed information about metastatic prostate cancer, they will be in a stronger position to make informed choices about their treatments, and the options available to them to extend their life or to enhance their quality of life,’’ Atkinson adds.
Graeme Woodside, chief executive officer of the Prostate Cancer Foundation explains that prostate cancer, and particularly endof-life treatment and care, is a topic that many men shy away from speaking about publicly.
‘‘We need to get better at talking about men’s health issues and prostate cancer specifically if we are to ensure men have access to resources and treatment options equal to that available for breast cancer. Only then can we hope to improve options and outcomes for New Zealand men with metastatic prostate cancer,’’ Woodside says.
In order to provide up to date information about prostate cancer progression, treatment options and pathways of care, an education session is being held at Novotel Ellerslie on Saturday August 23 from 1 to 4pm.
Leading specialists involved in the treatment and care of men with metastatic prostate cancer will present information about the disease, international treatment guidelines as well as the current treatment options and outcomes for New Zealand men.
Supported by personal stories from men living with metastatic prostate cancer, these sessions aim to explore the current challenges faced by New Zealand men and encourage men with advanced disease to talk about their futures and advocate for change.
Rea Wikaira, who is living with metastatic prostate cancer and worked in the healthcare system for more than 20 years, says his involvement with these education sessions is about giving metastatic prostate cancer a significant voice in our community.
‘‘I urge all men living with advanced prostate cancer to come along to these education sessions, to learn more about the disease, and to take an active role in defining their own future living with metastatic prostate cancer.’’